Improvement by the insulin-sensitizing agent, troglitazone, of abnormal fibrinolysis in type 2 diabetes mellitus

Metabolism: Clinical and Experimental

Volumn 49, Issue 5, 2000, Pages 662-665

  Kato, K ^a   Yamada, D ^a   Midorikawa, S ^a   Sato, W ^a   Watanabe, T ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLIBENCLAMIDE; HEMOGLOBIN A1C; INSULIN; ORAL ANTIDIABETIC AGENT; PLASMINOGEN ACTIVATOR INHIBITOR 1; SULFONYLUREA DERIVATIVE; TISSUE PLASMINOGEN ACTIVATOR; TROGLITAZONE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC RETINOPATHY; DRUG MECHANISM; FEMALE; FIBRINOLYSIS; GLUCOSE BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0034071999     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(00)80045-1     Document Type: Article

References (19)

1. Morrison AD Orci L Perrelet A Studies of the effects of an elevated glucose concentration on the ultrastructure composite metabolism of the intact rabbit aortic intima-media preparation Diabetes 29 1979 720 723
2. Brownlee M Vlassara H Cerami A Non-enzymatic glycosylation and the pathogenesis of diabetic complications Ann Intern Med 101 1984 527 537
3. Yorek MA Duulap JA The effect of the elevated glucose levels on myo -inositol metabolism in circulated aortic endothelial cells Metabolism 38 1989 16 22
4. Hamsten A de Faire U Walldius G Plasminogen activator inhibitor in plasma: Risk factor for recurrent myocardial infarction Lancet 2 1987 3 8
5. Gray RP Yudkin JS Patterson DL Plasminogen activator inhibitor: A risk factor for acute myocardial infarction in diabetic patients Br Heart J 69 1993 228 232
6. Dawson S Henney A The status of PAI-1 as a risk factor for arterial and thrombotic disease: A review Atherosclerosis 95 1991 105 117
7. Eliasson M Asplund K Evrin PE Hyperinsulinemia predicts low tissue plasminogen activator activity in a healthy population: The Northern Sweden MONICA Study Metabolism 12 1994 1579 1586
8. Juhan-Vague I Alessi MC Vague P Increased plasma plasminogen activator inhibitor-1 levels: A possible link between insulin resistance and atherothrombosis Diabetologia 34 1991 457 462
9. Suter SL Nolan JJ Wallance P Metabolic effects of new oral hypoglycemic agent CS-045 in NIDDM subjects Diabetes Care 15 1992 193 203
10. Ghazzi MN Perez JE Antonucci TK The Troglitazone Study Group: Cardiac and glycemic benefits of troglitazone treatment in NIDDM Diabetes 46 1997 433 439
11. Harano Y Ohgaku S Kosugi K Clinical significance of altered insulin sensitivity in diabetes mellitus assessed by glucose, insulin and somatostatin infusion J Clin Endocrinol Metab 2 1981 982 987
12. (abstr) Kato K Yamada D Midorikawa S Fibrinolytic activity in type 2 diabetic patients with microangiopathy J Jpn Diabetes Soc 41 1998 S215
13. Skrha J Hodinar A Kvasnicka J Relationship of oxidative stress and fibrinolysis in diabetes mellitus Diabet Med 13 1996 800 805
14. Nagi DK McCormark LJ Mohamed-Ali V Diabetic retinopathy, promoter (4G/5G) polymorphism of PAI-1 gene, and PAI-1 activity in Pima Indians with type 2 diabetes Diabetes Care 20 1997 1304 1309
15. Vague P Juhan-Vague I Alessi MC Metformin decreases high plasminogen activator inhibitor capacity, plasma insulin and triglyceride levels in non diabetic obese subjects Thromb Haemost 57 1987 326 328
16. Schneider DJ Nordt TK Sobel BE Attenuated fibrinolysis and accelerated atherogenesis in type 2 diabetic patients Diabetes 42 1993 1 7
17. Schneider DJ Nordt TK Sobel BE Stimulation by proinsulin of expression of plasminogen activator inhibitor type-1 in endothelial cells Diabetes 41 1992 8990 8995
18. Satoh H Tsukamoto K Hashimoto Y Thiazolidinediones suppress endothelin-1 secretion from bovine vascular endothelial cells: A new possible role of PPARγ on a vascular endothelial function Biochem Biophys Res Commun 254 1999 757 763
19. Kato K Satoh H Endo Y Thiazolidinediones downregulate plasminogen activator inhibitor type 1 expression in human vascular endothelial cells—A possible role of PPARγ on an endothelial function Biochem Biophys Res Commun 258 1999 431 435